Your browser doesn't support javascript.
loading
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.
Sidana, Surbhi; Kumar, Shaji; Fraser, Raphael; Estrada-Merly, Noel; Giralt, Sergio; Agrawal, Vaibhav; Anderson, Larry D; Aljurf, Mahmoud; Banerjee, Rahul; Bashey, Asad; Battiwalla, Minoo; Beitinjaneh, Amer; Chakraborty, Rajshekhar; Chhabra, Saurabh; Dhakal, Binod; Dholaria, Bhagirathbhai; Hashmi, Shahrukh; Janakiram, Murali; Lee, Cindy; Lekakis, Lazaros; Murthy, Hemant S; Parrondo, Ricardo; Wangjam, Tamna; Usmani, Saad; Shah, Nina; Qazilbash, Muzaffar; D'Souza, Anita.
Afiliação
  • Sidana S; Stanford University, Department of Medicine, Stanford, California. Electronic address: Surbhi.sidana@stanford.edu.
  • Kumar S; Mayo Clinic Rochester, Rochester, Division of Hematology, Department of Medicine, Minnesota.
  • Fraser R; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Estrada-Merly N; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Giralt S; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Agrawal V; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Anderson LD; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Banerjee R; Division of Hematology-Oncology; University of California San Francisco, San Francisco, California.
  • Bashey A; Blood and Marrow Transplant Program at the Northside Hospital, Atlanta, Georgia.
  • Battiwalla M; Sarah Cannon Blood Cancer Network, Nashville, Tennessee.
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.
  • Chakraborty R; Multiple Myeloma and Amyloidosis Service, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
  • Chhabra S; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dhakal B; BMT and Cellular Therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dholaria B; Vanderbilt University Medical Center, Department of Medicine, Nashville, Tennessee.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Minnesota; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Janakiram M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Lee C; Royal Adelaide Hospital, Adelaide, Australia.
  • Lekakis L; University of Miami, Department of Medicine, Miami, Florida.
  • Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Parrondo R; Mayo Clinic Florida, Department of Medicine, University of Miami, Miami, Florida.
  • Wangjam T; Louisiana State University Health, Department of Medicine, Shreveport, Louisiana.
  • Usmani S; Department of Hematologic Oncology & Blood Disorders Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
  • Shah N; Division of Hematology-Oncology; University of California San Francisco, San Francisco, California.
  • Qazilbash M; MD Anderson Cancer Center, Department of Stem Cell Transplantation, Houston, Texas.
  • D'Souza A; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: andsouza@mcw.edu.
Transplant Cell Ther ; 28(2): 83.e1-83.e9, 2022 02.
Article em En | MEDLINE | ID: mdl-34781066
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos